Group 1: Market Overview - The report provides a comprehensive overview of the quercetin powder market, including product definitions and statistical scope [2][3] - Quercetin powder can be categorized into several types, including anhydrous quercetin and dihydrate quercetin, with sales growth trends projected from 2021 to 2031 [2][3] - The applications of quercetin powder span across pharmaceuticals, food, cosmetics, and other sectors, with sales growth trends also forecasted for these applications [3] Group 2: Industry Background and Trends - The current status of the quercetin powder industry is analyzed, highlighting its historical development and future trends [3] - The report predicts the global quercetin powder supply and demand situation from 2021 to 2031, including capacity, production, and utilization rates [3][4] - Regional production trends and market shares for quercetin powder are examined, focusing on major regions from 2021 to 2031 [4] Group 3: Market Size and Sales Analysis - Global sales revenue and volume for quercetin powder are projected from 2021 to 2031, with price trends also included [4][5] - The report details the market share of major manufacturers in the quercetin powder sector, including production capacity and sales volume from 2021 to 2024 [5][6] - A detailed analysis of the sales revenue and market share of key manufacturers in China is also provided [6][7] Group 4: Competitive Landscape - The report identifies major global manufacturers of quercetin powder, detailing their production bases, sales regions, and market positions [5][6] - It includes a competitive analysis of the quercetin powder industry, focusing on market concentration and the competitive landscape among top manufacturers [6][7] - The report discusses recent investments and mergers in the quercetin powder market [7][8] Group 5: Product and Application Analysis - Different product types of quercetin powder are analyzed, including sales volume and revenue forecasts from 2021 to 2031 [8][9] - The report also examines the sales and revenue trends of quercetin powder across various applications, with projections for future growth [9][10] - Price trends for different product types and applications of quercetin powder are included in the analysis [10][11] Group 6: Supply Chain and Customer Analysis - An analysis of the quercetin powder industry chain is provided, including upstream raw material supply and downstream customer segments [11][12] - The report lists key suppliers of raw materials for quercetin powder and their contact information [12][13] - Typical customers and sales channels for quercetin powder are also discussed [13][14] Group 7: Opportunities and Challenges - The report identifies key growth opportunities and driving factors for the quercetin powder industry [14][15] - It also outlines potential risks and challenges faced by the industry, along with a policy analysis relevant to the quercetin powder market [15][16] - A SWOT analysis of Chinese enterprises in the quercetin powder sector is included [16]

撰文丨王聪 编辑丨王多鱼 排版丨水成文 播散性肿瘤细胞 （ Disseminated tumor cell，DTC） 可在远端器官中多年处于非增殖性的休眠状态，其 重新激活以及发生转移性定植的外源性诱因，目前尚不清楚。 2025 年 7 月 3 日，中国科学院上海营养与健康研究所 胡国宏 团队在 Cancer Cell 期刊发表了题为： Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps 的研 究论文。 该研究建立了 休眠肿瘤细胞谱系追踪系统 —— DormTracer ， 首次证实了休眠的播散性肿瘤细胞可苏醒 导致转移，并发现化疗激活休眠肿瘤细胞导致复发的作用及机制 ，这一发现解释了临床上观察到的乳腺癌 患者接受化疗获得初始疗效后往往难以避免后续发生转移复发的现象。 此外，该研究还提出了新型联合治疗策略—— S enolytic + 化疗 ，可抑制休眠的播散性肿瘤细胞在化疗后 的苏醒，为抑制肿瘤转移性复发提供了新方案。 该研究的亮点： 开发了一种基于重组酶的系统用于休眠肿瘤细 ...

Core Viewpoint - Selay is redefining the dietary supplement industry with a focus on personalized health solutions, combining natural ingredients with scientific innovation to cater to diverse consumer needs [1][5][7] Group 1: Product Philosophy - Selay emphasizes the importance of pure, natural ingredients sourced from plants and animals, ensuring high quality through rigorous selection processes [3] - The brand utilizes organic materials from local German farms and high-purity fish oil from Norway, achieving an Omega-3 content of 95% with minimal heavy metal residues [3] Group 2: Targeted Product Lines - Selay offers personalized product lines for various demographics, including blood sugar balance capsules for the elderly, hormone-regulating drinks for women, vitality supplements for men, and growth drinks for children [5] - Each product is designed to address specific health needs, such as cardiovascular health, metabolic balance, and developmental support for children [5] Group 3: Consumer Impact - The "Selay Arginine Capsule" exemplifies the brand's approach, combining ingredients like maca, arginine, oyster peptides, and zinc to significantly enhance physical strength and energy levels [7] - Selay aims to provide health solutions that resonate with different lifestyles, from busy professionals to health-conscious homemakers, ensuring that everyone can find their ideal health answer [7] Group 4: Future Outlook - The company is committed to ongoing research and innovation, with plans to expand its product line and offer more precise and effective nutritional solutions [7] - Selay envisions a future where health is easily accessible, promoting a lifestyle that harmonizes scientific advancements with natural wellness [7]

Core Viewpoint - SPRUTRITION's quercetin capsules are under investigation for false advertising and misleading health claims, with the product being removed from live sales but still available on other platforms [1][4]. Group 1: Investigation and Regulatory Actions - The Beijing Chaoyang District Market Supervision Administration has initiated an investigation into SPRUTRITION's trademark registration company, Yunshan Hengmao (Beijing) Enterprise Management Co., Ltd., based on allegations of false advertising [1]. - Following a report published on May 28, it was found that the product's claims of treating nodules lack clinical evidence and violate advertising laws [1][2]. Group 2: Product Availability and Marketing Claims - Despite the removal of the product from the SPRUTRITION live sales platform, it remains available on overseas flagship stores, where misleading claims about its efficacy in treating nodules persist [4][5]. - The product's promotional materials on various platforms include phrases suggesting it can "identify and eliminate nodules," which raises concerns about compliance with advertising regulations [3]. Group 3: Company Background - Yunshan Hengmao (Beijing) Enterprise Management Co., Ltd., the applicant for the SPRUTRITION trademark, was established on November 17, 2017, with a registered capital of 2 million RMB, categorizing it as a small and micro enterprise [5].

本次行动的核心任务，是在三年内帮助各类人群树立科学的体重管理观念，切实降低肥胖及相关慢性疾病的发病率。 ▍国人超重肥胖现象 《中国居民营养与慢性病状况报告》数据显示： 以下文章来源于体重管理三年行动 ，作者体重管理三年行动 体重管理三年行动 . 响应国家"健康中国2030"战略，落实"体重管理年"三年行动，本账号发布权威资讯 2025年3月9日，国家卫生健康委员会正式拉开了为期三年的"体重管理年"专项行动，旨在以科学减重和健康生活方式，积极应对我国不断加剧 的超重与肥胖难题。 我国6-17岁青少年儿童中，超重和肥胖比例已高达19%；成年人群的超重肥胖率更是达到50.7%。 过去15年，青少年肥胖率激增了12倍，职场人士"过劳肥"以及老年人肥胖问题也日益严重。肥胖不仅影响外观，还与高血压、糖尿病、心脑血 管疾病等多种慢性病紧密相关。这些慢性病的医疗负担占全国疾病总负担的70%以上，直接医疗支出每年超过2400亿元。 如何判断肥胖？ 主要依据BMI和腰围等指标。 BMI（体质指数）=体重（kg）÷身高（m）²，正常范围为18.5～23.9。 例如，身高1.66米、体重56公斤，则BMI=56÷（1.66×1.66 ...

Core Viewpoint - Shangde Life Health Industry Group aims to become a leading enterprise in health management services for high-income families globally, driven by the "Healthy China" and "Beautiful China" strategies [1][9]. Group 1: Achievements and Leadership - Shangde Life has made significant achievements in both domestic and international markets, with its chairman representing Chinese health brands at the Belt and Road Entrepreneurs Forum in 2023 [3]. - The group’s general manager participated in the 9th Doctor Cloud Conference, discussing the future of smart health with industry experts, highlighting its leadership position in the health sector [3]. Group 2: Research and Innovation - In 2024, the group plans to invest over 100 million USD to establish an international medical research laboratory focused on cutting-edge medical technology [6]. - The company is actively collaborating internationally, building 18 facilities, including a comprehensive stem cell building and research information center in countries like Tajikistan and Russia [6]. - Shangde Life enhances its core competitiveness in medical technology through the exclusive development of products like dihydroquercetin [6]. Group 3: Product Development - The group’s main brands reflect the traditional Chinese medicine concept of "food and medicine from the same source," utilizing modern extraction technologies to create effective health products [7]. - By integrating Western medical testing methods with traditional Chinese health principles, the company offers personalized health management services [7]. Group 4: Corporate Mission and Values - Shangde Life's mission is to "inherit traditional Chinese medicine and benefit human health," emphasizing values of integrity, responsibility, innovation, and win-win cooperation [8]. - The company aims to transform societal health concepts, providing professional and scientific health management services to a broader audience [8]. Group 5: Future Outlook - Looking ahead, Shangde Life intends to establish a global health management service center, leveraging its research capabilities, brand influence, and market advantages [9]. - The company will continue to deepen its commitment to traditional Chinese medicine and innovate products and services to enhance the health and happiness of its consumers [9].

2025欧洲国际营养保健食品展(Vitafoods Europe)于5月20日-5月22日在西班牙巴塞罗那盛大举行，德国高端膳食营养品牌VIKPRO携贵妇护巢丸新品及明星爆 款产品亮相。 值得一提的是，展会期间，凭借卓越的市场表现和产品实力，VIKpro荣膺全球权威市场调研机构欧睿国际颁发的辅酶Q10(还原型)和槲皮素双项第一市场地 位认证，成为名副其实的销量品质双冠王！这不仅是对VIKPRO在膳食营养领域发展的肯定，更是对其产品品质和品牌价值的高度认可。 德国科研实力加码，锻造行业持续引领力 立足德国，辐射全球。VIKPRO自德国启航，以严谨专业的德国研发生产工艺，持续深耕全球营养健康市场。此次亮相Vitafoods Europe并一举蝉联欧睿国际 双第一市场地位认证，也是品牌向全球展现科技实力的重要一环。 VIKPRO一直以来都坚持细胞级根源养护的健康理念，以德国科技为依托，不断升级突破创新技术。基于此，VIKPRO与德国杜塞尔多夫医科大学达成战略 合作，并签约3D细胞级磷脂复合技术研究引领者Prof.Dr.Nicole Teusch作为品牌首席科学顾问，进一步整合顶尖学术资源，融合其在学术研究、临床检验 ...

证券代码：833230 证券简称：欧康医药 公告编号：2025-049 成都欧康医药股份有限公司 投资者关系活动记录表 √特定对象调研 二、 投资者关系活动情况 活动时间：2025 年 5 月 27 日 活动地点：成都欧康医药股份有限公司 参会单位及人员：西南证券 上市公司接待人员：董事会秘书、财务总监：曹永强先生 三、 投资者关系活动主要内容 问题 1、请问公司主要核心产品价格变动情况及未来的价格走势如何？ 回复：公司产品根据原料丰收或歉收情况，采用成本加成与市场渗透相结 合的定价策略。2024 年，公司槐米系列产品（含槲皮素、芦丁、鼠李糖等）综 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 合单价同比下降 15%以上，枳实系列产品（含地奥司明、查尔酮、橙皮苷、枳 实黄酮等）综合单价同比上升 35%以上。今年新原料上市前，部分产品价格根 据市场行情有小幅度下调。 未来价格走势将取决于原料收成情况和与市场竞争格局变化，原料丰收时 产品价格随之下降，原料歉收时价格会上调。公司将持续优化产品结构，通过 新建项目实现量产来降低成本以对冲价格波动风险，提升公司产品在食品添加 剂 ...

证券代码：833230 证券简称：欧康医药 公告编号：2025-046 成都欧康医药股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 √特定对象调研 二、 投资者关系活动情况 活动时间：2025 年 5 月 15 日 活动地点：成都欧康医药股份有限公司 参会单位及人员：开源证券、华源证券、中睿合银、鲁信创投 上市公司接待人员：董事长、总经理：赵卓君先生；董事会秘书、财务总监： 曹永强先生 三、 投资者关系活动主要内容 问题 1、请问维生素行业整体价格下行对公司产品终端售价的影响？ □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 回复：维生素行业产品主要为维生素 A、维生素 B、维生素 C 等大的品 类，公司产品为维生素 P 类——黄酮类产品，属于细分赛道，主要以枳实、 槐米为原料，应用于药品原料、食品原料（食品添加剂）、化妆品原料、保 健品原料等领域。因此，维生素大行业的价格波动，对公司产品价格影响有 限， ...

Core Insights - Julydeer® is a dietary supplement brand founded in 2012 in Colorado, USA, focusing on "scientific, rigorous, innovative, and safe" principles in its product development and manufacturing [1] - The brand emphasizes technological innovation and has established a comprehensive R&D and production system for dietary supplements, ensuring product safety and efficacy through various certifications [1] - The company combines traditional herbal wisdom with modern scientific research, adhering to evidence-based medicine principles in its product formulations [1] Product Range - **Liver Protector: Milk Thistle Hard Capsules** - Contains 10,000mg of North American wild milk thistle seeds and 500mg of concentrated silymarin extract per serving - Designed for individuals with liver damage from alcohol, fatty liver, or abnormal liver indicators, showing clinical evidence of improving liver function [2] - **Cardiovascular Shield: Natto Hard Capsules** - Contains 150mg of natto kinase per bottle, supporting cardiovascular health with a gentle and safe thrombolytic effect [2] - **Krill Oil Soft Capsules** - Contains 1,000mg of Antarctic krill oil, enhancing Omega-3 absorption and showing significant effects on blood lipid regulation [3] - **Fish Oil Soft Capsules** - Contains 400mg of DHA and 100mg of EPA, supporting brain and eye health, particularly beneficial for children's brain development and elderly cognitive maintenance [4] - **Joint and Respiratory Health: Quercetin Hard Capsules** - Demonstrates a 15% reduction in blood uric acid levels and a 35% decrease in gout attack risk [6] - **Anti-Aging and Immune Support: PQQ Collagen Hard Capsules** - Activates mitochondrial function and reduces oxidative damage to skin cells [7] - **Astaxanthin Soft Capsules** - Features a patented extraction method that improves absorption by 260%, significantly enhancing its antioxidant effects [8] - **Women's Multivitamin Tablets** - Provides a comprehensive nutrient profile to improve hair loss and enhance immunity [9] - **Brain Health and Sleep Management: Phosphatidylserine Hard Capsules** - Supports cognitive function and alleviates anxiety, particularly beneficial for students and high-pressure workers [14] Brand Positioning - Julydeer® aims to redefine dietary supplements with a focus on "precision nutrition," adhering to high standards of purity, concentration, absorption, and transformation [1] - The brand's claims are supported by scientific literature, avoiding absolute terms and disease treatment claims, thus ensuring compliance with advertising laws and health food regulations [1]